CDE has actively participated in several related international meetings and activities with various objectives, such as the coordination of the APEC network of Pharmaceutical Regulatory Science, attending the International Conference on Harmonization (ICH) and supporting an “ICH in Taiwan” project, participating in meetings organized by the Drug Information Association (DIA), and so on. The Taiwanese regulatory environment and the advantages associated with an excellent infrastructure for conducting clinical trials were introduced on various occasions. Additionally, CDE maintains relationships with regulatory agencies of other countries. These agencies include FDA (USA), EMEA (EU), MHRA (UK), MPA (Sweden), TGA (Australia), PMDA (Japan), KFDA（Korea） and HSA (Singapore). These connections facilitated experience sharing and information updating.